Track record in oncology drug discovery and development
We have built a team that has successfully brought therapeutics to market, applying their expertise across all aspects of our organisation. A deep understanding of M&A data and commercial success ensures optimal project prioritisation.
Board of Directors
Mr Keith Murdoch
Interim Chairman & NXD
Entrepreneur and investment strategist. Expertise in deal negotiation and M&A activities as well as investor relations, financial modelling and business management.
Dr Clare Wareing
Founder & CEO
Senior Executive and entrepreneur with the vision, drive and experience of successful oncology drug development and company exits to lead the company forward. Company builder.
Catherine Lewis La Torre
NED
With over thirty years investment experience, specialising in private equity and venture capital, Catherine has led major UK financial organisations which support technology-driven businesses, including in the life sciences. In her most recent role as CEO of British Patient Capital, Catherine has been at the heart of investment in innovation.
Dr Sally Waterman
NED
Entrepreneur and biotech industry veteran with extensive drug development, commercialisation and board experience. Company builder.
Dr Diane Seimetz
NED
Entrepreneur and expert in the development and commercialisation of biologics. Company builder.
Dr Andrew McNeill
Investor Director
Serial entrepreneur and investor in the technology and life sciences sector. Expertise in company spin-outs, deal structure, investment and exit strategies. Company builder.
Clare Doris
Chief Development Officer
A life sciences entrepreneur with a successful career in building and managing companies in the sector. Clare plays a key role in Cumulus’ ambitious growth plans.
Dr Tim Sparey
Chief Business Officer
Highly motivated with 22 years of experience in blue chip big pharma, specialty pharma, and biotech. Held CEO and business development positions in companies focused on neuroscience, cancer, diabetes, and ophthalmology. Notable achievements include founding start-ups, fundraising, and major partnerships with Lundbeck and GSK. A strategic leader driving innovation and success in the biopharma industry.
Cumulus Core Team
Dr Clare Wareing
Founder & CEO
Senior Executive and entrepreneur with the vision, drive and experience of successful oncology drug development and company exits to lead the company forward. Company builder.
Jackie Macritchie
Chief Operating Officer
Experienced life science executive with over 30 years in the industry, specialised in driving strategic growth through global leadership and operational excellence.
Clare Doris
Chief Development Officer
A life sciences entrepreneur with a successful career in building and managing companies in the sector. Clare plays a key role in Cumulus’ ambitious growth plans.
Dr Ian Waddell
Chief Scientific Officer
Oncology focussed biochemist with more than 25 years’ experience and a proven track record of drug discovery in a variety of settings including large pharma, academic and CRO. Has interests in target identification / validation and synthetic lethal and epigenetics.
James Fair
Chief Financial Officer
A seasoned financial executive with a strong track record in driving financial strategies and operational excellence. Proven ability to navigate complex financial landscapes and deliver strategic solutions sets him apart as a trusted leader in the industry.
Dr Tim Sparey
Chief Business Officer
Highly motivated with 22 years of experience in blue chip big pharma, specialty pharma, and biotech. Held CEO and business development positions in companies focused on neuroscience, cancer, diabetes, and ophthalmology. Notable achievements include founding start-ups, fundraising, and major partnerships with Lundbeck and GSK. A strategic leader driving innovation and success in the biopharma industry.
Scott Doak
Group Finance Director
Entrepreneurial financial strategist with extensive experience of financial modelling and business management, deal negotiation and investor relations.
Dr Dominic James
Executive in Residence
With over 30 years of experience in drug discovery and molecular biology. As a seasoned CRO team leader, scientific consultant and freelance editor, Dominic offers valuable expertise in oncology.
Dr Thomas Wirth
Executive in Residence
Expertise in cell and gene therapy, combined with significant contributions to regulatory compliance, product development, fundraising, and operational efficiency. Proven track record in revenue generation and relationship building, establishing valuable partnerships within the industry.
Dr Tilly Bingham
Executive in Residence
Extensive experience in the pharmaceutical and biotech sectors, with a strong background in medicinal chemistry. Excels in strategic planning, managing intricate projects, and turning innovative ideas into influential products.
Dr Nikki March
Senior Director of Scientific Affairs
Highly skilled scientist, with over 20 years’ experience in the oncology area, spanning molecular signalling, signal transduction pathways and applications in drug discovery.
Dr Manuelle Debunne
Director of Scientific Affairs
Entrepreneurial scientist with proven ability to manage academic and industry programs to translate oncology assets towards clinical development.
Phil Chapman
Chief Data Scientist
Phil Chapman brings extensive expertise from AstraZeneca, Cancer Research UK, leveraging vast datasets to enhance oncology research and outcomes. His strategic vision and profound insights promise to elevate our data initiatives, driving us towards greater success and impact.
Laurent Jacqueroud
Business Development & Investment Director
Seasoned professional with experience in drug discovery, life science venture capital, and as a Business Development and Investment Director in UK oncology biotech. Proven expertise in addressing therapy challenges and accelerating patient access to treatments. Industry network builder.
Laura Gallagher
Senior Operations Lead (Program Management)
Experienced in academia, pharma, and CROs, specialising in oncology and immunology research. Skilled in managing early-stage preclinical projects, with expertise in novel immuno-oncology targets to redirect the immune system against tumours.
Daragh Campbell
Project Manager
Entrepreneurial scientist with industrial management experience to support executive and commercial teams.
Heather McGlashan
Finance Manager
An experienced Finance Manager with a background in Grant Payments, Contracts and Management Accounting and a Fellow of Chartered Certified Accountants. 15 years’ experience in the life science industry.
Nazila Ghandchi
Senior Administrator
Personal Assistant and administrator with over 15+ years’ experience, who has a passion for organisation and efficiency whilst working with a diverse range of clients.
We are hiring
Want to be part of a mission-led company in oncology drug development?
